GIC-backed Indian pharma Syngene buys Stelis Biopharma's manufacturing unit for $86m

GIC-backed Indian pharma Syngene buys Stelis Biopharma's manufacturing unit for $86m

Photo: Reuters

Anjali Ghodvaidya

06 July, 2023

Edited by: Pramod Mathew

Biocon BiologicsGICStelis Biopharma Pvt LtdSyngene International

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter

You may also like

Read more from India

Nikkei Logo
DealStreetAsia Logo
About Us
Team
Advertise
Contact
Careers
Blog
Privacy Policy
Terms & Conditions
© Copyright DEALSTREETASIA 2014-2025 All rights reserved.